Abstract
Post-stroke hyperglycaemia (PSH) is associated with higher mortality and dependence, but further data on predictors of PSH and its evolution over time are required. We examined the prevalence, predictors, and prognosis of acute PSH using data from well-characterised clinical trials in the VISTA database. Methods: Data were extracted for individual participants enrolled ¿1 blood glucose readings documented. PSH was defined as glucose >7.0 mmol/l. Outcome measures were: (1) prevalence of PSH; (2) predictors of PSH by binary logistic regression; (3) mortality, and (4) favourable functional outcome [modified Rankin Scale (mRS) score
Original language | English |
---|---|
Pages (from-to) | 17-27 |
Number of pages | 11 |
Journal | Cerebrovascular Diseases |
Volume | 1 |
Issue number | 1 |
Publication status | Published - 1 Jan 2011 |
Keywords
- post-stroke hyperglycaemia
- clinical trials
- VISTA